Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Anophthalmia/Microphthalmia/Coloboma/Anterior Segment Dysgenesis Asper Biogene Asper Biogene LLC Estonia | 37 | 35 |
|
Blueprint Genetics Finland | 1 | 18 |
|
Blueprint Genetics Finland | 6 | 27 |
|
MGZ Medical Genetics Center Germany | 6 | 167 |
|
Bioarray Spain | 1 | 1 |
|
Connective Tissue Laboratory Ghent University Hospital Belgium | 4 | 1 |
|
Connective Tissue Laboratory Ghent University Hospital Belgium | 4 | 3 |
|
MGZ Medical Genetics Center Germany | 2 | 65 |
|
Anterior Segment Dysgenesis, Axenfeld-Rieger Syndrome MGZ Medical Genetics Center Germany | 2 | 14 |
|
Fulgent Genetics United States | 4 | 1 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
Fulgent Genetics United States | 68 | 26 |
|
Comprehensive Eye Disorders NGS Panel Fulgent Genetics United States | 1018 | 459 |
|
LTBP2-Related Weill-Marchesani Syndrome MGZ Medical Genetics Center Germany | 1 | 1 |
|
LTBP2-Related Primary Congenital Glaucoma MGZ Medical Genetics Center Germany | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.